Pantocid 20 40 20 mg & 40 mg Enteric coated tablets.
PDF Leaflet Revision Date: 23 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of duodenal and gastric ulcers, reflux oesophagitis, and Zollinger-Ellison syndrome.
Dosage (summary)
PANTOCID 40: 40 mg once daily; PANTOCID 20: 20 mg once daily.
Special Populations
- Elderly
- Impaired renal function
- Mild to moderate liver impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Atazanavir
- NSAIDs
- HIV protease inhibitors
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Headache
- Diarrhoea
- Nausea
- Dizziness
- Abdominal pain
Counselling Points
- Take before or during breakfast
- Do not crush or chew tablets
- Report any severe skin reactions or gastrointestinal symptoms
Serious warnings
- Risk of Clostridium difficile-associated diarrhoea
- Monitor liver enzymes in severe liver impairment
- Risk of bone fractures
Important Disclaimer
The Pantocid 20 40 20 mg & 40 mg Enteric coated tablets. professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
